Christel Herold-Mende

Targeting tumor-associated macrophages in the immune-microenvironment of meningiomas

Use of biopsy-derived tumor organoids for personalized drug testing in recurrent glioblastoma

Automated drug screening in ependymoma organoids identifies HDAC, anthracyclines, and proteasome inhibitors as potential therapeutic candidates

Quantification of diverse immune cell subsets in primary meningiomas

Combinatorial drug screening identifies carfilzomib and enzalutamide for the treatment of aggressive meningiomas

The pharmacological atlas of meningiomas

Prospective longitudinal assessment of health-related quality of life and psycho-oncological burden in meningioma patients after tumor resection

Targeting tumor-associated macrophages in the immune-microenvironment of meningiomas

Central nervous solitary fibrous tumors: A case series of 49 patients

Use of biopsy-derived tumor organoids for personalized drug testing in recurrent glioblastoma

Stereotactic Laser Interstitial Thermal Therapy (LITT) and preclinical tumororganoid-based drug screening in recurrent high-grade glioma. First experiences from the Hi-SMILE study